2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors
| Errataetall: |
CommentIn: J Low Genit Tract Dis. 2020 Oct;24(4):426. - PMID 32732648 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
|---|---|
| Enthalten in: |
Journal of lower genital tract disease - 24(2020), 2 vom: 20. Apr., Seite 102-131 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Perkins, Rebecca B [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 17.03.2021 Date Revised 12.12.2022 published: Print CommentIn: J Low Genit Tract Dis. 2020 Oct;24(4):426. - PMID 32732648 Citation Status MEDLINE |
|---|
| doi: |
10.1097/LGT.0000000000000525 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM308287452 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM308287452 | ||
| 003 | DE-627 | ||
| 005 | 20231225131420.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1097/LGT.0000000000000525 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1027.xml |
| 035 | |a (DE-627)NLM308287452 | ||
| 035 | |a (NLM)32243307 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Perkins, Rebecca B |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 17.03.2021 | ||
| 500 | |a Date Revised 12.12.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentIn: J Low Genit Tract Dis. 2020 Oct;24(4):426. - PMID 32732648 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Practice Guideline | |
| 700 | 1 | |a Guido, Richard S |e verfasserin |4 aut | |
| 700 | 1 | |a Castle, Philip E |e verfasserin |4 aut | |
| 700 | 1 | |a Chelmow, David |e verfasserin |4 aut | |
| 700 | 1 | |a Einstein, Mark H |e verfasserin |4 aut | |
| 700 | 1 | |a Garcia, Francisco |e verfasserin |4 aut | |
| 700 | 1 | |a Huh, Warner K |e verfasserin |4 aut | |
| 700 | 1 | |a Kim, Jane J |e verfasserin |4 aut | |
| 700 | 1 | |a Moscicki, Anna-Barbara |e verfasserin |4 aut | |
| 700 | 1 | |a Nayar, Ritu |e verfasserin |4 aut | |
| 700 | 1 | |a Saraiya, Mona |e verfasserin |4 aut | |
| 700 | 1 | |a Sawaya, George F |e verfasserin |4 aut | |
| 700 | 1 | |a Wentzensen, Nicolas |e verfasserin |4 aut | |
| 700 | 1 | |a Schiffman, Mark |e verfasserin |4 aut | |
| 700 | 0 | |a 2019 ASCCP Risk-Based Management Consensus Guidelines Committee |e verfasserin |4 aut | |
| 700 | 1 | |a Arrindell, Deborah |e investigator |4 oth | |
| 700 | 1 | |a Batur, Pelin |e investigator |4 oth | |
| 700 | 1 | |a Carter, Alicia |e investigator |4 oth | |
| 700 | 1 | |a Cason, Patty |e investigator |4 oth | |
| 700 | 1 | |a Chen, Xiaojian |e investigator |4 oth | |
| 700 | 1 | |a Cheung, Li |e investigator |4 oth | |
| 700 | 1 | |a Choma, Kim |e investigator |4 oth | |
| 700 | 1 | |a Clarke, Megan |e investigator |4 oth | |
| 700 | 1 | |a Conageski, Christine |e investigator |4 oth | |
| 700 | 1 | |a Cremer, Miriam |e investigator |4 oth | |
| 700 | 1 | |a Crothers, Barbara |e investigator |4 oth | |
| 700 | 1 | |a Darragh, Teresa |e investigator |4 oth | |
| 700 | 1 | |a Demarco, Maria |e investigator |4 oth | |
| 700 | 1 | |a Duffey-Lind, Eileen |e investigator |4 oth | |
| 700 | 1 | |a Duron, Ysabel |e investigator |4 oth | |
| 700 | 1 | |a Egemen, Didem |e investigator |4 oth | |
| 700 | 1 | |a Eisenhut, Carol |e investigator |4 oth | |
| 700 | 1 | |a Felder, Tamika |e investigator |4 oth | |
| 700 | 1 | |a Feldman, Sarah |e investigator |4 oth | |
| 700 | 1 | |a Gold, Michael |e investigator |4 oth | |
| 700 | 1 | |a Goulart, Robert |e investigator |4 oth | |
| 700 | 1 | |a Han, Paul |e investigator |4 oth | |
| 700 | 1 | |a Hersh, Sally |e investigator |4 oth | |
| 700 | 1 | |a Holland, Aimee |e investigator |4 oth | |
| 700 | 1 | |a Huang, Eric |e investigator |4 oth | |
| 700 | 1 | |a Khan, Michelle |e investigator |4 oth | |
| 700 | 1 | |a Kupets, Rachel |e investigator |4 oth | |
| 700 | 1 | |a Long, Margaret |e investigator |4 oth | |
| 700 | 1 | |a Lorey, Thomas |e investigator |4 oth | |
| 700 | 1 | |a Loukissas, Jennifer |e investigator |4 oth | |
| 700 | 1 | |a Murphy, Jeanne |e investigator |4 oth | |
| 700 | 1 | |a Naresh, Amber |e investigator |4 oth | |
| 700 | 1 | |a Nelson, Erin |e investigator |4 oth | |
| 700 | 1 | |a Novetsky, Akiva |e investigator |4 oth | |
| 700 | 1 | |a Quinlan, Jeffrey |e investigator |4 oth | |
| 700 | 1 | |a Saslow, Debbie |e investigator |4 oth | |
| 700 | 1 | |a Sharpless, Kathryn |e investigator |4 oth | |
| 700 | 1 | |a Smith, Katie |e investigator |4 oth | |
| 700 | 1 | |a Stier, Elizabeth |e investigator |4 oth | |
| 700 | 1 | |a Stockdale, Colleen |e investigator |4 oth | |
| 700 | 1 | |a Tabbara, Sana |e investigator |4 oth | |
| 700 | 1 | |a Teoh, Deanna |e investigator |4 oth | |
| 700 | 1 | |a Unger, Elizabeth |e investigator |4 oth | |
| 700 | 1 | |a Waxman, Alan |e investigator |4 oth | |
| 700 | 1 | |a Welch, Kelly |e investigator |4 oth | |
| 700 | 1 | |a Werner, Claudia |e investigator |4 oth | |
| 700 | 1 | |a Wiser, Amy |e investigator |4 oth | |
| 700 | 1 | |a Zuna, Rosemary |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of lower genital tract disease |d 1997 |g 24(2020), 2 vom: 20. Apr., Seite 102-131 |w (DE-627)NLM096443464 |x 1526-0976 |7 nnns |
| 773 | 1 | 8 | |g volume:24 |g year:2020 |g number:2 |g day:20 |g month:04 |g pages:102-131 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1097/LGT.0000000000000525 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 24 |j 2020 |e 2 |b 20 |c 04 |h 102-131 | ||